title: Stelazine-induced pigmentation.
abstract: A case of a West Indian patient is reported who developed abnormal blue-grey pigmentation on exposed areas of skin following treatment with low dose stelazine. Oculocutaneous melanosis is a well-recognized side-effect of prolonged phenothiazine treatment. In this condition the areas of skin exposed to sunlight develop a violaceous, blue-grey or slate-grey colour in more severe cases. These characteristic changes are rarely seen now. We describe the case of a patient who developed pigmentation while taking a low dose of stelazine for 5 years.
authors.affiliation: Department of Dermatology, Royal Free Hospital, Hampstead, London, UK.
authors.forename: C
authors.initials: C
authors.lastname: Buckley
authors.forename: V
authors.initials: V
authors.lastname: Thomas
authors.forename: J
authors.initials: J
authors.lastname: Lewin
authors.forename: D
authors.initials: D
authors.lastname: Harris
authors.forename: M H
authors.initials: MH
authors.lastname: Rustin
mesh_terms: D000328:Adult; D005260:Female; D006801:Humans; D010859:Pigmentation Disorders / Q000139:chemically induced* / Q000473:pathology; D014268:Trifluoperazine / Q000009:adverse effects*
chemical_list: D014268:Trifluoperazine